Related references
Note: Only part of the references are listed.MS-1020 is a novel small molecule that selectively inhibits JAK3 activity
Byung-Hak Kim et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
NSC114792, a novel small molecule identified through structure-based computational database screening, selectively inhibits JAK3
Byung-Hak Kim et al.
MOLECULAR CANCER (2010)
STAT5 regulation of BCL10 parallels constitutive NFκB activation in lymphoid tumor cells
Zsuzsanna S. Nagy et al.
MOLECULAR CANCER (2009)
IL-21 is expressed in Hodgkin lymphoma and activates STAT5: evidence that activated STAT5 is required for Hodgkin lymphomagenesis
Ferenc A. Scheeren et al.
BLOOD (2008)
Characterization of 6q deletions in mature B cell lymphomas and childhood acute lymphoblastic leukemia
Emma Flordal Thelander et al.
LEUKEMIA & LYMPHOMA (2008)
JAKs in pathology: Role of Janus kinases in hematopoietic malignancies and immunodeficiencies
William Vainchenker et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2008)
The JAK kinases: Not just another kinase drug discovery target
Andrew F. Wilks
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2008)
Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cells
Lin Qiu et al.
BLOOD (2006)
Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma
T. Krejsgaard et al.
LEUKEMIA (2006)
BiNGO: a Cytoscape plugin to assess overrepresentation of Gene Ontology categories in Biological Networks
S Maere et al.
BIOINFORMATICS (2005)
IL-9 and its receptor: From signal transduction to tumorigenesis
L Knoops et al.
GROWTH FACTORS (2004)
The Janus kinases (Jaks)
K Yamaoka et al.
GENOME BIOLOGY (2004)
Share Paper
